유전자 치료 시장은 2023-2028년 67억 3,800만 달러 규모, 예측 기간 동안 23.31%의 CAGR로 성장할 것으로 예상됩니다.
본 보고서에서는 유전자 치료 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 특효약 지정 증가, 유전자 치료와 관련된 이익, 만성 질환의 유병률 증가 등이 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024 |
| 종료 연도 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2024년 |
18.59% |
| CAGR |
23.31% |
| 증분 금액 |
67억 3,800만 달러 |
이 보고서는 향후 몇 년간 유전자 치료 시장 성장을 주도할 주요 요인 중 하나로 CVD 및 희귀질환에 대한 유전자 치료 연구의 확대를 꼽았습니다. 또한, 신흥 경제국의 급속한 성장 잠재력과 유전자 치료 임상 파이프라인의 증가는 시장의 큰 수요를 창출할 것으로 보입니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장 전망 2023-2028
제4장 시장 규모 실적
- 세계 유전자 치료 시장 2018-2022
- 제공 방식별 부문 분석 2018-2022
- 치료 분야별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 제공 방식별
- 시장 세분화
- 비교 : 제공 방식별
- 생체내 : 시장 규모와 예측 2023-2028
- 생체외 : 시장 규모와 예측 2023-2028
- 시장 기회 : 제공 방식별
제7장 시장 세분화 : 치료 분야별
- 시장 세분화
- 비교 : 치료 분야별
- 종양학 : 시장 규모와 예측 2023-2028
- 중추신경계 : 시장 규모와 예측 2023-2028
- 안과 : 시장 규모와 예측 2023-2028
- 희귀질환 : 시장 규모와 예측 2023-2028
- 기타 : 시장 규모와 예측 2023-2028
- 시장 기회 : 치료 분야별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 중국 : 시장 규모와 예측 2023-2028
- 캐나다 : 시장 규모와 예측 2023-2028
- 일본 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역 상황별
제10장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제11장 경쟁 상황
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Abeona Therapeutics Inc
- Amgen Inc.
- Astellas Pharma Inc.
- Biogen Inc.
- bluebird bio Inc.
- ElevateBio
- F. Hoffmann La Roche Ltd.
- Generation Bio Co.
- Gilead Sciences Inc.
- Novartis AG
- Orchard Therapeutics Plc
- Poseida Therapeutics Inc.
- Sibiono GeneTech Co. Ltd.
- uniQure NV
- Voyager Therapeutics Inc
제13장 부록
ksm
The gene therapy market is forecasted to grow by USD 6738 mn during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.
Technavio's gene therapy market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 18.59% |
| CAGR | 23.31% |
| Incremental Value | $6738mn |
By Delivery Mode
By Therapy Area
- Oncology
- CNS
- Ophthalmology
- Rare diseases
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing research in gene therapy for cvds and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, rapid growth potential in developing economies and rise in clinical pipeline for gene therapy will lead to sizable demand in the market.
The report on the gene therapy market covers the following areas:
- Gene therapy market sizing
- Gene therapy market forecast
- Gene therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc, Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc, Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc., Sangamo Therapeutics Inc, Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc. Also, the gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Delivery Mode
- Executive Summary - Chart on Market Segmentation by Therapy Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Gene Therapy Market 2018 - 2022
- Historic Market Size - Data Table on Global Gene Therapy Market 2018 - 2022 ($ million)
- 4.2 Delivery Mode segment analysis 2018 - 2022
- Historic Market Size - Delivery Mode Segment 2018 - 2022 ($ million)
- 4.3 Therapy Area segment analysis 2018 - 2022
- Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Delivery Mode
- 6.1 Market segments
- Chart on Delivery Mode - Market share 2023-2028 (%)
- Data Table on Delivery Mode - Market share 2023-2028 (%)
- 6.2 Comparison by Delivery Mode
- Chart on Comparison by Delivery Mode
- Data Table on Comparison by Delivery Mode
- 6.3 In vivo - Market size and forecast 2023-2028
- Chart on In vivo - Market size and forecast 2023-2028 ($ million)
- Data Table on In vivo - Market size and forecast 2023-2028 ($ million)
- Chart on In vivo - Year-over-year growth 2023-2028 (%)
- Data Table on In vivo - Year-over-year growth 2023-2028 (%)
- 6.4 Ex vivo - Market size and forecast 2023-2028
- Chart on Ex vivo - Market size and forecast 2023-2028 ($ million)
- Data Table on Ex vivo - Market size and forecast 2023-2028 ($ million)
- Chart on Ex vivo - Year-over-year growth 2023-2028 (%)
- Data Table on Ex vivo - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Delivery Mode
- Market opportunity by Delivery Mode ($ million)
- Data Table on Market opportunity by Delivery Mode ($ million)
7 Market Segmentation by Therapy Area
- 7.1 Market segments
- Chart on Therapy Area - Market share 2023-2028 (%)
- Data Table on Therapy Area - Market share 2023-2028 (%)
- 7.2 Comparison by Therapy Area
- Chart on Comparison by Therapy Area
- Data Table on Comparison by Therapy Area
- 7.3 Oncology - Market size and forecast 2023-2028
- Chart on Oncology - Market size and forecast 2023-2028 ($ million)
- Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
- Chart on Oncology - Year-over-year growth 2023-2028 (%)
- Data Table on Oncology - Year-over-year growth 2023-2028 (%)
- 7.4 CNS - Market size and forecast 2023-2028
- Chart on CNS - Market size and forecast 2023-2028 ($ million)
- Data Table on CNS - Market size and forecast 2023-2028 ($ million)
- Chart on CNS - Year-over-year growth 2023-2028 (%)
- Data Table on CNS - Year-over-year growth 2023-2028 (%)
- 7.5 Ophthalmology - Market size and forecast 2023-2028
- Chart on Ophthalmology - Market size and forecast 2023-2028 ($ million)
- Data Table on Ophthalmology - Market size and forecast 2023-2028 ($ million)
- Chart on Ophthalmology - Year-over-year growth 2023-2028 (%)
- Data Table on Ophthalmology - Year-over-year growth 2023-2028 (%)
- 7.6 Rare diseases - Market size and forecast 2023-2028
- Chart on Rare diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Rare diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Rare diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Rare diseases - Year-over-year growth 2023-2028 (%)
- 7.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Therapy Area
- Market opportunity by Therapy Area ($ million)
- Data Table on Market opportunity by Therapy Area ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Abeona Therapeutics Inc
- Abeona Therapeutics Inc - Overview
- Abeona Therapeutics Inc - Product / Service
- Abeona Therapeutics Inc - Key offerings
- 12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 12.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- 12.6 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- 12.7 bluebird bio Inc.
- bluebird bio Inc. - Overview
- bluebird bio Inc. - Product / Service
- bluebird bio Inc. - Key offerings
- 12.8 ElevateBio
- ElevateBio - Overview
- ElevateBio - Product / Service
- ElevateBio - Key offerings
- 12.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.10 Generation Bio Co.
- Generation Bio Co. - Overview
- Generation Bio Co. - Product / Service
- Generation Bio Co. - Key offerings
- 12.11 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- 12.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.13 Orchard Therapeutics Plc
- Orchard Therapeutics Plc - Overview
- Orchard Therapeutics Plc - Product / Service
- Orchard Therapeutics Plc - Key offerings
- 12.14 Poseida Therapeutics Inc.
- Poseida Therapeutics Inc. - Overview
- Poseida Therapeutics Inc. - Product / Service
- Poseida Therapeutics Inc. - Key news
- Poseida Therapeutics Inc. - Key offerings
- 12.15 Sibiono GeneTech Co. Ltd.
- Sibiono GeneTech Co. Ltd. - Overview
- Sibiono GeneTech Co. Ltd. - Product / Service
- Sibiono GeneTech Co. Ltd. - Key offerings
- 12.16 uniQure NV
- uniQure NV - Overview
- uniQure NV - Product / Service
- uniQure NV - Key offerings
- 12.17 Voyager Therapeutics Inc
- Voyager Therapeutics Inc - Overview
- Voyager Therapeutics Inc - Product / Service
- Voyager Therapeutics Inc - Key news
- Voyager Therapeutics Inc - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
